The World Market for Prescription Orthopedic Drugs

Questions: Discounts, Updates etc.

Pages: 180

Price (Single): $3500

Price (Company): $7000

Publication Date: 2006-10-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, and Genentech are developing or offering products in more niche market areas.

For the purposes of this study, the world market for orthopedic drugs has been segmented in a few general treatment segments:

In each segment, the report discuses common orthopedic diseases and conditions in general and provides detailed information on individual diseases and conditions and treatment approaches. Each segment provides an overview, world and U.S. prevalence of the various conditions, a detailed description of products on the market, products in the research and development pipeline, and market estimates and forecasts by geographical region (U.S. vs non-U.S.) and by treatment type, including:

Competitive market share by leading supplier and leading drug are also provided in each segment, and the report reviews current business, regulatory, and clinical issues and trends affecting the industry and the direction of research and commercialization.

The research conducted by Kalorama Information included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Person-to-person and telephone interviews were the primary method of gathering information. Interviews with over 75 key industry officials, consultants, health care providers, and government personnel were complied to form the primary basis of information - specifically the revenue and market share data - presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertain to the manufacturers’ level. The base year for data was 2005. Historical revenue data are provided for 2003 and 2004, with forecasts provided for 2006 through 2010. Market share information is provided for 2005. Compound annual growth rates (CAGRs) are provided for three periods in each industry segment: 2003-2005, 2005-2010, and 2003-2010.

Table of Contents

Chapter one: Executive Summary

Chapter Two: Introduction

chapter Three: Arthritis Treatments

chapter Four: Bone Loss Treatments (Osteoporosis and Paget’s Disease)

 

  • Market Size and Growth
    • Market by Product Type
    • Markets by Geographical Segments
    • U.S. Market
    • Non-U.S. Market
  • Competitive Analysis

    chapter Five: Growth Disorder Treatments

    • Description of Growth Disorders
      • Acromegaly
      • Growth Hormone Deficiency
    • Description of Products
      • Polypeptide Hormones
      • Somatostatin Analogs
    • Research and Development
      • Gentropin
      • Omnitrope
      • ALTU-238
    • Market Size and Growth
      • Market by Product Type
      • Markets by Geographical Segment
      • U.S. Market
      • Non-U.S. Market
    • Competitive Analysis

    chapter Six: Other Orthopedic Treatments

    • Description of Products
      • Antibiotics
      • Bone Cancer Drugs
      • Bone Pain Drugs
      • Skeletal Muscle Relaxants
    • Research and Development
      • Chrysalin
      • Junovan
      • OMS 103HP
    • Market Size and Growth
      • Market by Treatment Type
      • Markets by Geographical Segments
      • U.S. Market
      • Non-U.S. Market
    • Competitive Analysis

    Chapter Seven: Issues and Trends Affecting the Orthopedic Drug Market

    • New Therapies for Osteoporosis
      • Osteobiologics
      • Up-and-Coming Advances
    • The Elderly
    • Obesity
    • Labeling
    • FDA Actions
    • Vitamin D and Black Women
    • DTC Advertising

    Chapter Eight: Orthopedic Drugs Market Size and Forecast Summary

    • Overview
    • Total Market Size and Forecast
      • Markets by Therapeutic Segment
    • Competitive Analysis

    chapter Nine: Company Profiles

    • Introduction
    • Abbott Laboratories
    • Amgen, Inc.
    • Boehringer Ingelheim GmbH
    • Chugai Pharmaceutical Company Ltd.
    • Eli Lilly & Company
    • Johnson & Johnson
    • Merck & Company, Inc.
    • Novartis International AG
    • Novo Nordisk
    • Pfizer, Inc.
    • The Procter and Gamble Company
    • Sanofi-Aventis
    • Schering-Plough Corporation
    • Wyeth

    Appendix: Company Directory

     

    List of Exhibits

     

    Chapter one: Executive Summary

    • Figure 1-1: Market Summary: World Market Orthopedic Drugs 2003-2010
    • Table 1-2: Orthopedic Drugs: Leading Suppliers Significant Segments of Participation, 2005

    Chapter Two: Introduction

    • Table 2-1: Population by Country (Autralia, Canada, France, Germany, Italy,Japan, United Kingdom, United States) 2003-2010
    • Figure 2-1: Population by Significant Market Country (Autralia, Canada,France, Germany, Italy, Japan, United Kingdom, United States)2005 vs. 2010
    • Table 2-2: Estimated World and U.S. Prevalence of Major OrthopedicConditions

    chapter Three: Arthritis Treatments

    • Table 3-1: Estimated U.S. and World Prevalence of Arthritis Conditions(Ankylosing Spondylitis, Juvenile Rheumatoid Arthritis,Osteoarthritis, Psoriatic Arthritis, Reactive Arthritis,Rheumatoid Arthritis)
    • Figure 3-1: Estimated World Prevalence of Arthritis Conditions
    • Table 3-2: Products in Research and Development for Arthritis (Product,Developer, Indication, Development Phase/Status)
    • Table 3-3: World Market Arthritis Treatments Total Revenues and GrowthRates 2003-2010
    • Figure 3-2: Trending in the World Market Arthritis Treatments 2003-2010
    • Table 3-4: World Market Arthritis Treatments Revenues and GrowthRates by Product Type (NSAIDS/Cox-2 vs. Antirheumatoids and Combinations) 2003-2010
    • Figure 3-3: World Market Arthritis Treatments Trending by ProductType 2003-2010
    • Table 3-5: World Market Arthritis Treatments by Geographical Segment(U.S. vs Non-U.S.) 2003-2010
    • Figure 3-4: Trending in the World Market Arthritis Treatments byGeographical Segment 2003-2010
    • Table 3-6: World Market Arthritis Treatments Revenues and Market Share by Leading Suppliers Estimated 2005 and Projected 2010
    • Table 3-7: World Market Arthritis Treatments Estimated Sales and MarketShare by Leading Product 2005
    • Figure 3-5: Market Share of Top Arthritis Drugs 2005

    chapter Four: Bone Loss Treatments (Osteoporosis and Paget’s Disease)

    • Table 4-1: Estimated U.S. and World Prevalence of Bone Loss Conditions byType (Osteoporosis, Paget’s Disease, Hypercalcemia,Low Bone Mass)
    • Figure 4-1: Estimated World Prevalence of Bone Loss Conditions by Type (Osteoporosis, Paget’s Disease, and Other)
    • Table 4-2: Products in Research and Development for Osteoporosis, Paget’sDisease and Other Bone Loss Disorders (Product, Developer, Development Phase/Status, Projected Approval Date)
    • Table 4-3: World Market Bone Loss Treatments Total Revenues andGrowth Rates 2003-2010
    • Figure 4-2: Trending in the World Market Bone Loss Treatments 2003-2010
    • Table 4-4: World Market Bone Loss Treatments by Product Type (SERMS & Estrogen Combinations, Bisphosphonates, Calcitonins) 2003-2010Figure 4-3: Trending in the World Market Bone Loss Treatments byProduct Type
    • Table 4-5: World Market Bone Loss Treatments by Geographical Segment (U.S. vs Non-U.S.) 2003-2010
    • Figure 4-4: Trending in the World Market Bone Loss Treatments byGeographical Segment 2003-2010
    • Table 4-6: World Market Bone Loss Treatments Revenues and MarketShare by Leading Suppliers Estimated 2005 and Projected 2010
    • Table 4-7: World Market Bone Loss Treatments Estimated Sales andMarket Share by Leading Product 2005

    chapter Five: Growth Disorder Treatments

    • Table 5-1: Estimated U.S. and World Prevalence of Growth Disorders by Type (Acromegaly, Pediatric GH Deficiency, Adult GH Deficiency)
    • Figure 5-1: Estimated World Prevalence of Growth Disorders
    • Table 5-2: Products in Research and Development for Growth Disorders(Product, Developer, Development Phase/Status, ProjectedApproval Date)
    • Table 5-3: World Market for Growth Disorder Treatments Total Revenues and Growth Rates 2003-2010
    • Figure 5-2: Trending in the World Market Growth Disorder Treatments,2003-2010
    • Table 5-4: World Market for Growth Disorder Treatments by Product Type (Polypeptide Hormones vs Sandostatin Analogs) 2003-2010
    • Figure 5-3: Trending in the World Market for Growth Disorder Treatments by Product Type 2003-2010
    • Table 5-5: World Market for Growth Disorder Treatments by GeographicalSegment (U.S. vs Non-U.S.) 2003-2010
    • Figure 5-4: Trending in the World Market for Growth Disorder Treatments by Geographical Segment 2003-2010
    • Table 5-6: World Market Arthritis Treatments Revenues and Market Share by Leading Suppliers Estimated 2005 and Projected 2010

    chapter Six: Other Orthopedic Treatments

    • Table 6-1: Estimated U.S. and World Prevalence of Ankylosing Spondylitis,Juvenile Rheumatoid Arthritis, Osteoarthritis, PsoriaticArthritis, Reactive Arthritis, and Rheumatoid Arthritis
    • Figure 6-1: Estimated World Prevalence of Arthritis Conditions
    • Table 6-2: Products in Research and Development for Other OrthopedicIndications (Product, Developer, Development Phase/Status,Indication, Projected Approval Date)
    • Table 6-3: World Market for Other Orthopedic Treatments Total Revenues and Growth Rates 2003-2010
    • Table 6-4: World Market for Other Orthopedic Treatments by Product Type(Pain Treatments, Muscle Relaxants, Others) 2003-2010
    • Figure 6-2: Trending in the World Market for Other Orthopedic Treatments by Product Type 2003-2010
    • Table 6-5: World Market for Other Orthopedic Treatments by Geographical Segment (U.S. vs Non-U.S.) 2003-2010
    • Figure 6-3: Trending in the World Market for Other Orthopedic Treatments by Geographical Segment 2003-2010

    Chapter Eight: Orthopedic Drugs Market Size and Forecast Summary

    • Table 8-1: World Market for Orthopedic Drugs Total Revenues andGrowth Rates 2003-2010
    • Figure 8-1: Trending in the World Market Orthopedic Drugs, 2003-2010
    • Table 8-2: World Market for Orthopedic Drugs by Therapeutic Segment2003-2010
    • Figure 8-2: Trending in the World Market for Orthopedic Drugs by Therapeutic Segment 2003-2010
    • Figure 8-3: World Market for Orthopedic Drugs Revenue Distribution by Therapeutic Segment 2005
    • Table 8-3: Orthopedic Drugs: Leading Suppliers Significant Segments of Participation, 2005

     

    •  

    Other users found this report page using the following search terms: Orthopedic Orthopaedic Arthritis Treatments Osteoporosis Paget’s Disease Bone Loss Growth Disorder Ankylosing Spondylitis market size orthopedic spondylitis world drugs drug ankylosing ostarine bisphosphonates

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.